Dr. Pouria Motevalian

Dr. Motevalian has received his PhD. in Chemical Engineering from the Pennsylvania State University and is currently serving as principal scientist in BioProcess R&D in Pfizer. Over the past several years in Pfizer, he has been leading the evaluation and implementation of new technologies such as bioprocess digital twin and single-use filtration for vaccines. Additionally, he has been leading process development activities for early and late stage programs and contributed to regulatory filings for Pneumococcal 20-valent conjugate vaccine and Covid-19 mRNA vaccine.